Assessing the Impact of Headaches and the Outcomes
of Treatment: A Systematic Review of Patient-
reported Outcome Measures (PROMs)
Cephalalgia 2018 (Jun); 38 (7): 13741386~ FULL TEXT
Although many PROMs were reviewed following their evaluation in the headache and/or migraine population, study methodological quality was often poor and evidence of essential measurement properties largely unavailable or limited. Such limitations hinder PROM data interpretation from clinical trials, audit, or quality assurance initiatives. However, three measures
Headache Impact Test 6-item (HIT-6),
Migraine-Specific Quality of Life Questionnaire (MSQ v2.1)
Patient Perception of Migraine Questionnaire (PPMQ-R) had acceptable, and often strong, evidence of reliability and validity following completion by patients with headache (HIT-6) or migraine (HIT-6, MSQv2.1, PPMQ-R), and are recommended for consideration in future clinical research and routine practice settings as measures of headache-specific impact, migraine-specific impact, or migraine-treatment response respectively. However, the similarity of item content across all three measures suggests that a further exploration of the attribution, relevance and acceptability of the measures with representative members of the patient population is warranted. Further comparative evidence of widely-used generic measures and evidence of measurement responsiveness of all measures is urgently required.